About B3B

This author has not yet filled in any details.
So far B3B has created 231 blog entries.

Spotlight: Every Challenge. Every Day. Every Voice.

Behind every patient stands thousands of scientists and researchers working together to develop life-saving treatments. So what happens when a patient meets the people that helped save her life? Watch this 8-minute documentary as Ginger Tam, a lung-cancer patient, meets the researchers who worked on her cancer treatment.  

March 1st, 2017|

Event Recap: PMWC 2017

Shaping Patient-Centric Health Care By Marie Daghlian Rapid advances in genomics and technology are transforming personalized medicine into precision medicine. Genomic medicine is here, Euan Ashley said as he welcomed a gathering of more than 8,000 people to the Precision Medicine World Conference (PMWC) held in Silicon Valley. Ashley, director of Stanford University’s Clinical Genomics [...]

February 6th, 2017|

Event Recap: BioWeekSF Spotlight – Rare in the Square/Biotech Showcase Panel

Developing Therapies for Rare Diseases: Patients Come First By Marie Daghlian Rare disease drug development is personal and often driven by patient advocacy. In a lively and engaging fireside chat titled “Unmet needs, uncommon commitment: shift toward investment in rare diseases,” Henri Termeer, an early advocate of rare disease drug development and a serial entrepreneur, [...]

January 23rd, 2017|

Event Recap: Biotech Showcase 2017 – “Looking Ahead” Workshop Focus

Upbeat Mood but Uncertainty Ahead By Marie Daghlian The Hilton Hotel at Union Square in downtown San Francisco hummed with energy as more than 3,300 life sciences professionals converged for the ninth annual Biotech Showcase during the second week of January 2017. Held at the same time as the annual J.P. Morgan Healthcare Conference, neither [...]

January 23rd, 2017|

Event Recap: RESI SF 2017

Networking on Steroids: Early stage entrepreneurs speed date with investors at RESI in San Francisco By Marie Daghlian You have 30 minutes per meeting, enough time to make your pitch, find out if there is a potential connection, and move on to the next meeting. It’s networking on steroids and it works for many of [...]

January 18th, 2017|

September Spotlight:

  The Innovative Genomics Initiative (IGI) is currently soliciting applications for its new Entrepreneurial Fellows Program at UC Berkeley. Designed to catalyze the translation and commercialization of innovative research discoveries for practical benefit, this new program builds strong support networks in which accomplished, entrepreneurial-minded researchers are enabled to make substantial contributions to the biotech economy, [...]

September 23rd, 2016|

September Spotlight:
Charles River Hosting Viral Clearance and Viral Safety Summit in Foster City

Date: October 18 – 19, 2016 Location: Crowne Plaza Hotel, 1221 Chess Drive, Foster City, CA 94404 Agenda/Registration: www.criver.com/summit16 This two-day summit, located in the eclectic Bay Area, unites industry professionals in an interactive setting to share updates and discuss trends in the realm of viral safety and viral clearance.  Also, during the summit, four [...]

August 25th, 2016|

Gilead Takes ‘Low Road’

Full feature More coverage: TheStreet: Gilead Sciences Bucks Tradition, Takes 'Low Road' on New Hepatitis C Drug Price More FierceBiotech: New Gilead hep C combo Epclusa gains FDA approval More STAT: FDA approves a Gilead pill that is first to treat all forms of hepatitis C More

June 29th, 2016|

Event Recap: Medical Devices Take the Spotlight

By Marie Daghlian; Photos by Eugene Borodin A smart contact lens that monitors blood glucose, video games that promise to enhance cognition, a novel and simple biopsy device that improves patient comfort—these are just a few of the next generation of medical devices showcased at the third annual Rosenman Institute Symposium, held June 22nd at Byers [...]

June 29th, 2016|

KaloBios Reinvents Itself and How to Price Drugs

From The Bio Report/Daniel Levine: "KaloBios, a biotech best known for a series of disastrous events including failed clinical trials, a bankruptcy filing, lawsuits, and the arrest of its CEO, is being reborn. In the process, it may provide a valuable contribution to the ongoing discussion over drug pricing. In April, the development-stage company unveiled [...]

June 23rd, 2016|